Pseudo-enzymatic hydrolysis of 4-nitrophenyl myristate by human serum albumin

Biochemical and Biophysical Research Communications

Volumn 422, Issue 2, 2012, Pages 219-223

  Ascenzi, Paolo ^a,b   Fasano, Mauro ^c  

^a ROMA TRE UNIVERSITY   (Italy)

^b NATIONAL INSTITUTE OF BIOSTRUCTURES AND BIOSYSTEMS   (Italy)

^c UNIVERSITY OF INSUBRIA   (Italy)

Author keywords

4 Nitrophenyl myristate; AMPSO; Bis Tris; Hepes; HSA; Human serum albumin; MyOH; NphOH; NphOMy; PH effects; Pseudo enzymatic hydrolysis

Indexed keywords

4 NITROPHENYL MYRISTIC ACID; DIAZEPAM; HUMAN SERUM ALBUMIN; MYRISTIC ACID DERIVATIVE; NUCLEOPHILE; UNCLASSIFIED DRUG;

ACETYLATION; ARTICLE; BINDING AFFINITY; CHEMICAL MODIFICATION; DEACYLATION; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME KINETICS; HUMAN; HYDROLYSIS; LIGAND BINDING; PH; PRIORITY JOURNAL;

DIAZEPAM; ESTERASES; HUMANS; HYDROGEN-ION CONCENTRATION; HYDROLYSIS; MYRISTATES; SERUM ALBUMIN;

EID: 84861707562     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.04.111     Document Type: Article

References (22)

1. All about Albumin: Biochemistry, Genetics and Medical Applications 1996, Academic Press, San Diego and London. T. Peters (Ed.).
2. Curry S. Beyond expansion: structural studies on the transport roles of human serum albumin. Vox Sang. 2002, 83(Suppl. 1):315-319.
3. Fasano M., Curry S., Terreno E., Galliano M., Fanali G., Narciso P., Notari S., Ascenzi P. The extraordinary ligand binding properties of human serum albumin. IUBMB Life 2005, 57:787-796.
4. Curry S. Lessons from the crystallographic analysis of small molecule binding to human serum albumin. Drug. Metab. Pharmacokinet. 2009, 24:342-357.
5. Fanali G., di Masi A., Trezza V., Marino M., Fasano M., Ascenzi P. Human serum albumin: from bench to bedside. Mol. Aspects Med. 2012, 33:209-290.
6. Lockridge O., Xue W., Gaydess A., Grigoryan H., Ding S.J., Schopfer L.M., Hinrichs S.H., Masson P. Pseudo-esterase activity of human albumin: slow turnover on tyrosine 411 and stable acetylation of 82 residues including 59 lysines. J. Biol. Chem. 2008, 283:22582-22590.
7. Chen R.F. Removal of fatty acids from serumalbumin by charcoal treatment. J. Biol. Chem. 1967, 242:173-181.
8. Sogami M., Foster J.F. Isomerization reactions of charcoal-defatted bovine plasma albumin. The N-F transition and acid expansion. Biochemistry 1968, 7:2172-2182.
9. Cabrera-Crespo J., Goncalves V.M., Martins E.A., Grellet S., Lopes A.P., Raw I. Albumin purification from human placenta. Biotechnol. Appl. Biochem 2000, 31:101-106.
10. Means G.E., Bender M.L. Acetylation of human serum albumin by p-nitrophenyl acetate. Biochemistry 1975, 14:4989-4994.
11. Sakurai Y., Ma S.F., Watanabe H., Yamaotsu N., Hirono S., Kurono Y., Kragh-Hansen U., Otagiri M. Esterase-like activity of serum albumin: characterization of its structural chemistry using p-nitrophenyl esters as substrates. Pharmcol. Res. 2004, 21:285-292.
12. Hollaway M.R., Antonini E., Brunori M. The pH-dependence of rates of individual steps in ficin catalysis. Eur. J. Biochem. 1971, 24:332-341.
13. Antonini E., Ascenzi P. The mechanism of trypsin catalysis at low pH proposal for a structural model. J. Biol. Chem. 1981, 256:12449-12455.
14. Curry S., Brick P., Franks N.P. Fatty acid binding to human serum albumin: new insights from crystallographic studies. Biochim. Biophys. Acta 1999, 1441:131-140.
15. Bhattacharya A.A., Grüne T., Curry S. Crystallographic analysis reveals common modes of binding of medium and long-chain fatty acids to human serum albumin. J. Mol. Biol. 2000, 303:721-732.
16. Ghuman J., Zunszain P.A., Petitpas I., Bhattacharya A.A., Otagiri M., Curry S. Structural basis of the drug-binding specificity of human serum albumin. J. Mol. Biol. 2005, 353:38-52.
17. P. Ascenzi, M.G. Ascenzi, G. Amiconi, Enzyme competitive inhibition. Graphical determination of Ki and presentation of data in comparative studies, 15 (1987) 134-135.
18. Fanali G., Cao Y., Ascenzi P., Trezza V., Rubino T., Parolaro D., Fasano M. Binding of δ9-tetrahydrocannabinol and diazepam to human serum albumin. IUBMB Life 2011, 63:446-451.
19. Peller L., Alberty R.A. Multiple intermediates in steady state enzyme kinetics. I. The mechanism involving a single substrate and product. J. Am. Chem. Soc. 1959, 81:5907-5914.
20. Sugio S., Kashima A., Mochizuki S., Noda M., Kobayashi K. Crystal structure of human serum albumin at 2.5å resolution. Protein Eng. 1999, 12:439-446.
21. Yang F., Bian C., Zhu L., Zhao G., Huang Z., Huang M. Effect of human serum albumin on drug metabolism: structural evidence of esterase activity of human serum albumin. J. Struct. Biol. 2007, 157:348-355.
22. Liyasova M.S., Schopfer L.M., Lockridge O. Reaction of human albumin with aspirin in vitro: mass spectrometric identification of acetylated lysines 199, 402, 519 and 545. Biochem. Pharmacol. 2010, 79:784-791.